Royal Bank of Canada’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-61,902
Closed -$1.68M 7000
2015
Q4
$1.68M Sell
61,902
-3,018
-5% -$77.7K ﹤0.01% 2690
2015
Q3
$1.42M Buy
64,920
+3,426
+6% +$87.4K ﹤0.01% 2548
2015
Q2
$1.75M Buy
61,494
+124
+0.2% +$3.61K ﹤0.01% 2427
2015
Q1
$1.68M Sell
61,370
-29,795
-33% -$820K ﹤0.01% 2426
2014
Q4
$2.41M Buy
91,165
+23,950
+36% +$701K ﹤0.01% 2186
2014
Q3
$2.03M Buy
67,215
+10,424
+18% +$323K ﹤0.01% 2292
2014
Q2
$1.79M Sell
56,791
-3,232
-5% -$103K ﹤0.01% 2378
2014
Q1
$1.94M Sell
60,023
-1,641
-3% -$57.4K ﹤0.01% 2268
2013
Q4
$2.24M Buy
61,664
+6,810
+12% +$265K ﹤0.01% 2219
2013
Q3
$2.13M Buy
54,854
+6,029
+12% +$243K ﹤0.01% 2163
2013
Q2
$1.83M Buy
+48,825
New +$1.93M ﹤0.01% 2117

Other funds holding MR

Royal Bank of Canada's MR Position: Q1 2016 in Review

Royal Bank of Canada sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 61,902 shares — an estimated $1.68M sold.

Royal Bank of Canada first reported a position in MR in Q2 2013 and held it in 11 quarters. The position peaked at $2.41M in Q4 2014. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

  • Royal Bank of Canada reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
  • Royal Bank of Canada sold 61,902 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $1.68M.
  • Royal Bank of Canada first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 11 quarters.
  • Royal Bank of Canada's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $2.41M in Q4 2014.
  • 2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on Royal Bank of Canada's 13F filing for Q1 2016, filed 16 May 2016.